Phase 1 Autism Spectrum Disorder Trial, Recruiting (NCT06293950)

Phase 1 Autism Spectrum Disorder Trial, Recruiting NCT06293950 Sponsor: University of Jordan Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06293950 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children between 4 and 14 years of age who have been diagnosed with Autism Spectrum Disorder (ASD)

Who may not be able to join:

Children older than 14 years of age
Children who weigh less than 10 kg (approximately 22 pounds)
Anyone with a history of severe allergic reactions
Anyone with a history of serious head injury, such as one that caused loss of consciousness, required a hospital stay, involved a broken skull, or resulted in a stroke
Anyone who has had a seizure within the past year, or who currently takes or has previously taken seizure medications
Anyone with a serious or uncontrolled ongoing health condition affecting the body (confirm with trial site)
Anyone who would not be able to follow the required medication schedule and attend all follow-up appointments
Anyone currently taking stimulant or non-stimulant medications used for ADHD — these must be stopped at least 7 days before the study begins
Anyone taking a type of antidepressant called an SSRI must have been on a stable, unchanged dose for at least 30 days before joining the study
Anyone who was born prematurely before 35 weeks of pregnancy
Anyone who had a stroke or other serious injury before birth (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Abdallah Awidi, MD, Cell Therapy Center

Phone: 00962798871087

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06293950

Sponsor: University of Jordan

Phase: Phase 1

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 00962798871087

More information: https://clinicaltrials.gov/study/NCT06293950

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children between 4 and 14 years of age who have been diagnosed with Autism Spectrum Disorder (ASD)

Who may not be able to join:

Children older than 14 years of age
Children who weigh less than 10 kg (approximately 22 pounds)
Anyone with a history of severe allergic reactions
Anyone with a history of serious head injury, such as one that caused loss of consciousness, required a hospital stay, involved a broken skull, or resulted in a stroke
Anyone who has had a seizure within the past year, or who currently takes or has previously taken seizure medications
Anyone with a serious or uncontrolled ongoing health condition affecting the body (confirm with trial site)
Anyone who would not be able to follow the required medication schedule and attend all follow-up appointments
Anyone currently taking stimulant or non-stimulant medications used for ADHD — these must be stopped at least 7 days before the study begins
Anyone taking a type of antidepressant called an SSRI must have been on a stable, unchanged dose for at least 30 days before joining the study
Anyone who was born prematurely before 35 weeks of pregnancy
Anyone who had a stroke or other serious injury before birth (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

University of Jordan

Registry

ClinicalTrials.gov

Start date

9 March 2022

Est. completion

1 June 2026

Where this trial is recruiting

🇯🇴 Jordan

Primary endpoints

safety profile lab tests

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov